For research use only
| Cat No. | ABC-TC3991 |
| Product Type | Immune Cells |
| Cell Type | T Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Peripheral Blood CD8+ T Killer Cells provide primary cytotoxic T cells for immunology, cellular therapy, and functional signaling pathway studies.
Human Peripheral Blood (PB) CD8+ T Killer Cells are isolated from the peripheral blood of healthy donors. Following primary culture, these cells are cryopreserved. As a core component of the adaptive immune system, CD8+ T cells are responsible for recognizing and eliminating virus-infected, cancerous, or otherwise damaged cells. These cells are defined by the expression of the CD8 surface molecule, which plays a critical role in antigen recognition and immune defense. Studies have linked CD8+ T cell dysfunction with autoimmune disorders such as multiple sclerosis and rheumatoid arthritis. In addition, they are important targets in the development of cancer immunotherapies. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Peripheral Blood CD8+ T Killer Cells, PB CD8+ Cytotoxic T Cells, Circulating CTLs, CD8+ T Lymphocytes |
| Species | Human |
| Cat.No | ABC-TC3991 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | T Cell |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Immune Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Peripheral Blood CD8+ T Killer Cells are widely used as an in vitro model to investigate cytotoxic immune responses, viral clearance mechanisms, and tumor cell lysis. These cells play a crucial role in adaptive immunity and are ideal for studying antigen-specific activation, perforin/granzyme-mediated cytotoxicity, and TCR signaling. They can also be used to evaluate immunotherapeutic strategies such as checkpoint blockade and T cell–based adoptive therapies. Their relevance in viral infection models, tumor immunology, and autoimmune disease research makes them highly valuable for translational and preclinical studies.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).